Edgemond James
United Therapeutics Corp · CFO AND TREASURER
Edgemond James is listed in filings as CFO AND TREASURER at United Therapeutics Corp. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to United Therapeutics Corp (UTHR). The current snapshot covers public activity from May 15, 2026 to Jun 5, 2026. Reported amounts are shown as $46.3K to $169.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $66k120 shares | SellJun 4, 2026 | $550.48 | $532.27 | |
| $713k1.3k shares | SellJun 4, 2026 | $549.06 | $532.27 | |
| $2M2.7k shares | SellJun 4, 2026 | $548.04 | $532.27 | |
| $565k1k shares | SellJun 4, 2026 | $547.00 | $532.27 | |
| $616k1.1k shares | SellJun 4, 2026 | $545.89 | $532.27 | |
| $842k1.5k shares | SellJun 4, 2026 | $544.94 | $532.27 | |
| $591k1.1k shares | SellJun 4, 2026 | $544.11 | $532.27 | |
| $239k440 shares | SellJun 4, 2026 | $542.78 | $532.27 | |
| $260k480 shares | SellJun 4, 2026 | $541.14 | $532.27 | |
| $65k120 shares | SellJun 4, 2026 | $539.64 | $532.27 |